Panacea Biotec Ltd. reported the total number of shares dematerialized as of October 31, 2024, amounting to 6,10,89,525 shares, with 5,31,95,258 shares in NSDL and 78,94,267 shares in CDSL. A detailed certificate from Skyline Financial Services Pvt. Ltd. confirming these figures is also included. The report provides clarity on the shares transitioned to a dematerialized format during October 2024 for investor records.